Illumina agrees to $9.8 million settlement over cybersecurity vulnerabilities in genomic sequencing systems
MLex Summary: Illumina agreed to pay $9.8 million to resolve allegations that it violated the False Claims Act when it sold to federal agencies certain genomic sequencing systems with cybersecurity vulnerabilities,...To view the full article, register now.
Already a subscriber? Click here to view full article